Jason Tardio
Chief Operating Officer chez OVID THERAPEUTICS INC.
Fortune : 85 781 $ au 31/03/2024
Profil
Jason Tardio's career history includes current and former positions as well as his education.
Currently, he is the Chief Operating Officer at Ovid Therapeutics, Inc. Prior to this, he held the position of General Manager & MD-Latin America South at Biogen, Inc. from 2017 to 2018.
He also served as the VP & Head-Multiple Sclerosis Franchise at Novartis, Inc. in 2019.
In terms of education, Mr. Tardio obtained an undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OVID THERAPEUTICS INC.
0,04% | 22/02/2024 | 28 125 ( 0,04% ) | 85 781 $ | 31/03/2024 |
Postes actifs de Jason Tardio
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Operating Officer | 08/07/2021 |
Anciens postes connus de Jason Tardio
| Sociétés | Poste | Fin |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | 01/11/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2018 |
Formation de Jason Tardio
| The College of New Jersey | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| OVID THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
